174 related articles for article (PubMed ID: 32482675)
1.
Cheng Z; Xu Z; Tian H; Liu F; Li X; Luo D; Wang Y
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32482675
[TBL] [Abstract][Full Text] [Related]
2. EGF-mediated EGFR/ERK signaling pathway promotes germinative cell proliferation in Echinococcus multilocularis that contributes to larval growth and development.
Cheng Z; Liu F; Li X; Dai M; Wu J; Guo X; Tian H; Heng Z; Lu Y; Chai X; Wang Y
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005418. PubMed ID: 28241017
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo efficacy of thiacloprid against Echinococcus multilocularis.
Liu C; Fan H; Ma J; Ma L; Ge RL
Parasit Vectors; 2021 Sep; 14(1):450. PubMed ID: 34488852
[TBL] [Abstract][Full Text] [Related]
4. In vitro metacestodicidal activities of genistein and other isoflavones against Echinococcus multilocularis and Echinococcus granulosus.
Naguleswaran A; Spicher M; Vonlaufen N; Ortega-Mora LM; Torgerson P; Gottstein B; Hemphill A
Antimicrob Agents Chemother; 2006 Nov; 50(11):3770-8. PubMed ID: 16954323
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro efficacy of crocin against Echinococcus multilocularis.
Liu C; Fan H; Guan L; Ge RL; Ma L
Parasit Vectors; 2021 Jul; 14(1):364. PubMed ID: 34256821
[TBL] [Abstract][Full Text] [Related]
6. Targeting Echinococcus multilocularis PIM kinase for improving anti-parasitic chemotherapy.
Koike A; Becker F; Sennhenn P; Kim J; Zhang J; Hannus S; Brehm K
PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010483. PubMed ID: 36190997
[TBL] [Abstract][Full Text] [Related]
7. In Vitro and in Vivo Effect of MAPK Signal Transduction Pathway Inhibitors on Echinococcus multilocularis.
Gui WF; Xu S; Dang ZS; Zhao YM
J Parasitol; 2019 Feb; 105(1):146-154. PubMed ID: 30807708
[TBL] [Abstract][Full Text] [Related]
8. Metformin Suppresses Development of the Echinococcus multilocularis Larval Stage by Targeting the TOR Pathway.
Loos JA; Dávila VA; Brehm K; Cumino AC
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32540980
[TBL] [Abstract][Full Text] [Related]
9. Effect of sunitinib against Echinococcus multilocularis through inhibition of VEGFA-induced angiogenesis.
Jiang H; Wang X; Guo L; Tan X; Gui X; Liao Z; Li Z; Chen X; Wu X
Parasit Vectors; 2023 Nov; 16(1):407. PubMed ID: 37936208
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling of Echinococcus multilocularis miRNAs throughout metacestode development in vitro.
Macchiaroli N; Preza M; Pérez MG; Kamenetzky L; Cucher M; Koziol U; Castillo E; Berriman M; Brehm K; Rosenzvit MC
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009297. PubMed ID: 33750964
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.
Küster T; Stadelmann B; Hermann C; Scholl S; Keiser J; Hemphill A
Antimicrob Agents Chemother; 2011 Feb; 55(2):713-21. PubMed ID: 21135182
[TBL] [Abstract][Full Text] [Related]
12. Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis.
Rufener R; Ritler D; Zielinski J; Dick L; da Silva ET; da Silva Araujo A; Joekel DE; Czock D; Goepfert C; Moraes AM; de Souza MVN; Müller J; Mevissen M; Hemphill A; Lundström-Stadelmann B
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):331-340. PubMed ID: 29933218
[TBL] [Abstract][Full Text] [Related]
13. In vivo activity of albendazole in combination with thymol against Echinococcus multilocularis.
Albani CM; Pensel PE; Elissondo N; Gambino G; Elissondo MC
Vet Parasitol; 2015 Sep; 212(3-4):193-9. PubMed ID: 26190130
[TBL] [Abstract][Full Text] [Related]
14. In vitro metabolomic footprint of the Echinococcus multilocularis metacestode.
Ritler D; Rufener R; Li JV; Kämpfer U; Müller J; Bühr C; Schürch S; Lundström-Stadelmann B
Sci Rep; 2019 Dec; 9(1):19438. PubMed ID: 31857639
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Allicin Against Alveolar Echinococcosis In Vitro and in a Mouse Model.
Liu C; Fan H; Guan L; Ma L; Ge RL
Acta Parasitol; 2022 Mar; 67(1):79-93. PubMed ID: 34143400
[TBL] [Abstract][Full Text] [Related]
16. Targeting Echinococcus multilocularis stem cells by inhibition of the Polo-like kinase EmPlk1.
Schubert A; Koziol U; Cailliau K; Vanderstraete M; Dissous C; Brehm K
PLoS Negl Trop Dis; 2014 Jun; 8(6):e2870. PubMed ID: 24901228
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of albendazole in combination with thymol against Echinococcus multilocularis protoscoleces and metacestodes.
María AC; Celina EM
Acta Trop; 2014 Dec; 140():61-7. PubMed ID: 25149355
[TBL] [Abstract][Full Text] [Related]
18. Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis.
Rufener R; Dick L; D'Ascoli L; Ritler D; Hizem A; Wells TNC; Hemphill A; Lundström-Stadelmann B
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):440-450. PubMed ID: 30396011
[TBL] [Abstract][Full Text] [Related]
19. Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis.
Lundström-Stadelmann B; Rufener R; Hemphill A
Int J Parasitol Drugs Drug Resist; 2020 Aug; 13():121-129. PubMed ID: 32636148
[TBL] [Abstract][Full Text] [Related]
20. Impairing the maintenance of germinative cells in Echinococcus multilocularis by targeting Aurora kinase.
Cheng Z; Liu F; Tian H; Xu Z; Chai X; Luo D; Wang Y
PLoS Negl Trop Dis; 2019 May; 13(5):e0007425. PubMed ID: 31095613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
